Purchase Order 36C26126P0576
Award Date 3/26/26
Potential Completion Date 6/25/26
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Edwards Lifesciences LLC received a $32.5K firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics restocking. The contract, awarded on February 9, 2026, carries an ultimate completion date of May 8, 2026, with performance taking place at the VA Palo Alto Health Care System in San Francisco, California. No set-aside designation was utilized...
- Edwards Lifesciences LLC received a $68,000 firm fixed-price purchase order from Veterans Integrated Service Network (VISN) 21, part of the Department of Veterans Affairs, for transcatheter aortic valve replacement (TAVR) prosthetic devices. The contract, awarded on March 16, 2026, with an ultimate completion date of the same day, will be performed in Palo Alto, California. This award carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced...
- Edwards Lifesciences LLC received a firm fixed-price purchase order valued at $68,000 from Veterans Integrated Service Network 21 (VISN 21) for two transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on February 17, 2026, with completion targeted for the same date, will support cardiac surgical services at the VA Palo Alto Health Care System in Palo Alto, California. This procurement carries no set-aside designation and represents a specialized medical device...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation, has been awarded a firm fixed-price purchase order valued at $32,500 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetics. The contract, which carries no set-aside designation, is scheduled for completion by March 14, 2026, with the place of performance located in San...
- Edwards Lifesciences LLC has been awarded a $32.5K firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for the restock of transcatheter aortic valve replacement (TAVR) surgical implants. The contract, awarded on December 30, 2025, has an ultimate completion date of March 29, 2026, and will be performed in San Francisco, California. No set-aside designation was used for this procurement, and Edwards Lifesciences LLC serves as both the prime contractor and sole...
- Edwards Lifesciences LLC has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 21 (VISN 21) for prosthetics related to transcatheter aortic valve replacement (TAVR) procedures. The contract, awarded on December 8, 2025, has an ultimate completion date of January 8, 2026, and will be performed in Palo Alto, California. This purchase order represents a direct procurement of specialized cardiovascular medical devices from Edwards Lifesciences LLC, the...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 21, awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 29, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants restocking. The contract, with performance completion by April 28, 2026, supports the VA Palo Alto Health Care System's cardiac surgical program by replenishing inventory of specialized cardiovascular devices. This award carries no set-aside designation...
- The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded Edwards Lifesciences LLC a $65,000 firm fixed-price purchase order on January 15, 2026, for transcatheter aortic valve replacement (TAVR) surgical implants and related prosthetic devices to support the VA Palo Alto Health Care System. This award carries no set-aside designation and represents a restocking procurement executed under the company's existing five-year, $6.5 million indefinite delivery...
- Edwards Lifesciences LLC has been awarded a firm fixed-price purchase order valued at $32,500 for transcatheter aortic valve replacement (TAVR) surgical implants and prosthetics restocking. The contract, awarded December 30, 2025, with an ultimate completion date of March 29, 2026, will be performed in San Francisco, California, and funded by Veterans Integrated Service Network 21, a component of the U.S. Department of Veterans Affairs. This award carries no set-aside designation and...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, has been awarded a $204,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 21 for prosthetics related to transcatheter aortic valve replacement (TAVR) procedures. The contract, awarded on January 13, 2026, with an ultimate completion date of February 13, 2026, will be performed in Palo Alto, California. This award represents a...